Anamorelin as a Therapeutic Option for Cancer Cachexia in Advanced Pancreatic Cancer: A Case Report Demonstrating Significant Weight Gain and Quality of Life Improvement

被引：1

作者：

Kan, Motoyasu ^{[1
,2
]}

Ogane, Yoshiki ^{[1
]}

Watabe, Kazuki ^{[1
]}

Takahashi, Tomoya ^{[1
]}

Sakai, Miho ^{[1
]}

Sekine, Yu ^{[1
]}

Yamada, Nana ^{[1
]}

Sugihara, Chihei ^{[1
]}

Ouchi, Mayu ^{[1
]}

Nagashima, Hiroki ^{[1
]}

Takahashi, Koji ^{[2
]}

Okitsu, Koichiro ^{[1
]}

Ohyama, Hiroshi ^{[1
]}

Ohno, Izumi ^{[2
]}

Kato, Naoya ^{[1
]}

机构：

[1] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan

[2] Chiba Univ, Grad Sch Med, Dept Oncol, Chiba, Japan

来源：

INTERNAL MEDICINE | 2025年

关键词：

Pancreatic cancer; Supportive care; Cancer cahexia; Ghrelin; Anamorelin; CELL LUNG-CANCER; DOUBLE-BLIND;

D O I：

10.2169/internalmedicine.4708-24

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cancer cachexia, which is characterized by weight loss and muscle weakness, is common in patients with pancreatic cancer. Anamorelin, a ghrelin receptor agonist, has shown potential for the management of cachexia in various cancers. We herein report a 64-year-old man with unresectable pancreatic cancer who experienced significant weight gain with anamorelin, allowing for continued chemotherapy and an improved quality of life. Despite disease progression, his response suggests the potential utility of anamorelin as a supportive therapy. Cachexia's complex metabolic changes make treatment difficult; however, anamorelin's appetite and weight gain effects highlight its possible role in managing cachexia in pancreatic cancer. Therefore, further research is required in this regard.

引用

页数：6

共 50 条

[41] Omega-3 polyunsaterated fatty acids improve quality of life and survival, but not body weight in cancer cachexia: A systematic review and meta-analysis of controlled trials [J].

Jin, Xin ;

Xu, Xin-Tian ;

Tian, Meng-Xing ;

Dai, Zhu .

NUTRITION RESEARCH, 2022, 107 :165-178

[42] First reported advanced pancreatic cancer with hyperprogression treated with PD-1 blockade combined with chemotherapy: a case report and literature review [J].

Wang, Ya-Zhou ;

Peng, Mao-Zhen ;

Xu, Yao-Lin ;

Ying, Ying ;

Tang, Lin-Hui ;

Xu, Hua-Xiang ;

He, Jun-Yi ;

Liu, Liang ;

Wang, Wen-Quan .

DISCOVER ONCOLOGY, 2024, 15 (01)

[43] Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature [J].

Valeri, S. ;

Borzomati, D. ;

Nappo, G. ;

Perrone, G. ;

Santini, D. ;

Coppola, R. .

PANCREATOLOGY, 2014, 14 (05) :425-430

[44] Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy — a retrospective observational study [J].

Hironori Fujii ;

Maaya Koda ;

Shiori Sadaka ;

Koichi Ohata ;

Hiroko Kato-Hayashi ;

Hirotoshi Iihara ;

Ryo Kobayashi ;

Takuma Ishihara ;

Shinya Uemura ;

Takuji Iwashita ;

Hideki Hayashi ;

Tadashi Sugiyama ;

Masahito Shimizu ;

Akio Suzuki .

Journal of Pharmaceutical Health Care and Sciences, 7

[45] Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational study [J].

Fujii, Hironori ;

Koda, Maaya ;

Sadaka, Shiori ;

Ohata, Koichi ;

Kato-Hayashi, Hiroko ;

Iihara, Hirotoshi ;

Kobayashi, Ryo ;

Ishihara, Takuma ;

Uemura, Shinya ;

Iwashita, Takuji ;

Hayashi, Hideki ;

Sugiyama, Tadashi ;

Shimizu, Masahito ;

Suzuki, Akio .

JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2021, 7 (01)

[46] Two-staged treatment with local resection and percutaneous isolated hepatic chemoperfusion for advanced pancreatic cancer with multiple liver metastases: Report of a case [J].

Suzuki, Y ;

Ku, Y ;

Tominaga, M ;

Kamigaki, T ;

Fujino, Y ;

Tanioka, Y ;

Iwasaki, T ;

Fukumoto, T ;

Takeyama, Y ;

Kuroda, Y .

HEPATO-GASTROENTEROLOGY, 2001, 48 (38) :574-577

[47] Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) [J].

Romanus, Dorothy ;

Kindler, Hedy L. ;

Archer, Laura ;

Basch, Ethan ;

Niedzwiecki, Donna ;

Weeks, Jane ;

Schrag, Deborah .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2012, 43 (02) :205-217

[48] Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial [J].

Anwar, Sidra ;

Tan, Wei ;

Yu, Jinhee ;

Hutson, Alan ;

Javle, Milind ;

Iyer, Renuka .

JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (06) :433-439

[49] Efficacy of relative dose intensity of nab-paclitaxel for the short-term outcomes, survival, and quality of life in patients with advanced pancreatic cancer: a retrospective study [J].

Lian, Lian ;

Shen, Xiao-Ming ;

Huang, Tie-Ao ;

Li, Da-Peng ;

Li, Xian-Min ;

Han, Shu-Guang ;

Xu, Xue-Fei ;

Ma, Chun-Tao ;

Zhou, Chong .

TRANSLATIONAL CANCER RESEARCH, 2022, 11 (07) :2310-2320

[50] Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3 [J].

Vickers, M. M. ;

Lee, C. ;

Tu, D. ;

Wheatley-Price, P. ;

Parulekar, W. ;

Brundage, M. D. ;

Moore, M. J. ;

Au, H. ;

O'Callaghan, C. J. ;

Jonker, D. J. ;

Ringash, J. ;

Goldstein, D. .

PANCREATOLOGY, 2016, 16 (06) :1106-1112

← 1 2 3 4 5 →